Searched for
ROCKET PHARMA SHARES
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%The official kickoff of the Q4 earnings season happens when a large IT company announces its results, although the quarter’s business updat...- US Stocks: Rocket Pharma shares fall 15% despite FDA nod for childhood disorder treatmentRocket Pharmaceuticals' shares dropped significantly after gaining FDA approval for Kresladi, a gene therapy for a rare childhood immune di...
- GCCs step up hiring; Valentine’s Day sales surgeHappy Friday! Global capability centres are ramping up hiring in 2026, even as AI-led automation reshapes certain roles. That and more in t...
- Russian arguments have no credibility: Ukraine initiates probe into attack on Indian pharma warehouseThe Ukrainian Embassy in India has refuted Russia's denial regarding the attack on the Indian pharma company Kusum's warehouse in Kyiv, cal...
- One reason is enough to stay with them for the long term. 7 large cap stocks from different sectors with an upside potential of up to 28%What makes a stock move from mid cap to large cap ? One is the technical reason which gets impacted by what definition, regulator and excha...
- Getting to space is incredibly tough. Agnikul is doing it on a 3D-printed rocket engineIt took just 6.5 years for Chennai startup Agnikul Cosmos to use a rocket with a 3D-printed engine. It promises to revolutionise spacetech.
- Ahead of Market: 10 things that will decide D-Street action on TuesdayThe benchmark NSE Nifty 50 index lost 0.18% to 21,418 points, while the S&P BSE Sensex settled 0.24% lower at 71,315.
- Safe sparklers & high-risk rockets or value bombs? Vivek Karwa’s 6 picks“In the high risk category, my first bet would be Prakash Industries. This company again should cross Rs 200 levels. The other risky one is...
- Which companies are affected by Silicon Valley Bank collapse?The collapse also raised concerns that rising interest rates could expose vulnerabilities in the global economy as a decades-long era of ch...
- Roblox, Buzzfeed, other companies affected by Silicon Valley Bank collapseStartup-focused lender SVB Financial Group last week became the largest bank to fail since the 2008 financial crisis, sending shockwaves th...
- Commodities can be the next big thing to look out for: Deven ChokseyI think we have been holding onto ports and transmission and I think we continue to hold both these companies looking at the fundamental st...
- High input costs pinch India Inc; margins to fall for first time in 12 quartersCorporate profitability, as defined by the earnings before interest, taxes, depreciation and ammortisation (Ebitda) margin, likely dropped ...
- Sensex jumps 295 pts as investors turn blind eye to Omicron woesThe 30-share pack Senex advanced 295.93 points or 0.52 per cent to close at 57,420.24. The index gyrated about 970 points during the day.
- Trade hit as freight costs from China risesShipping companies have jacked up rates over the last year by adding peak season surcharge and other increases, which vary with shipping li...
- India Inc wants the sum of its parts to be 'China Plus One'India imports merchandise worth around $70 billion from China annually, largely in sectors like consumer durables, auto components, pharma ...
- Economy may not improve much but global cues to drive markets in 2020: Ajay SrivastavaExpect the same stock market results like in 2019, unless there are drastic policy changes.
- Nifty, Sensex remain dull; midcap & smallcap indices hit record highsSustained selling in private bank, auto and IT stocks kept the benchmark indices in the lower range.
- ETMarkets Morning Podcast: What's buzzing on D-Street this morning?Tune in to the morning briefing of news, views and cues before you start your day on Dalal Street.
- Too hard to digest: Food Panda co-founders on a controversyAkhilesh Bali and Amit Kohli, who are no longer employed there, were among the first to help set up the food delivery service in India.
- Pick defensive pharma stocks to hedge against global risks: Ajay BaggaEven as we have seen some selling from institutional investors, I would suggest investors to own pharma stocks from a multi-year perspectiv...
Load More
